Bailard, Inc. Satsuma Pharmaceuticals, Inc. Transaction History

Bailard, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.54 - $7.17 $93,070 - $146,985	-20,500 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$4.8 - $7.25 $98,400 - $148,625	20,500 New	20,500 $145,000
Q4 2020 Feb 03, 2021	SELL	$3.56 - $5.09 $137,416 - $196,474	-38,600 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$3.85 - $28.47 $148,610 - $1.1 Million	38,600 New	38,600 $150,000

Ticker STSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,587,500
Description
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.